Skip to main content

Table 3 Corticotropin-releasing hormone/growth hormone-releasing factor/luteinizing hormone-releasing hormone stimulation test in July 2016 (day 5 after admission)

From: Acute hypopituitarism associated with periorbital swelling and cardiac dysfunction in a patient with pituitary tumor apoplexy: a case report

  Reference range for basal value Time (min)
0 (Basal) 15 30 60 90 120
Serum GH (ng/mL) 0–0.17 0.03 0.41 1.11 1.30 0.92 0.35
Plasma ACTH (pg/mL) 7.2–63.3 15.4 90.1 91.7 75.8 66.5 60.4
Serum cortisol (μg/dL) 4.5–21.1 1.1 2.7 4.5 5.1 5.2 4.9
Serum LH (mIU/mL) 0.8–5.7 0.5 1.0 1.4 1.7 2.0 1.9
Serum FSH (mIU/mL) 2.0–8.3 2.0 2.9 3.1 3.8 3.9 4.0
  1. The following were administered intravenously in the morning (9 AM): 100 μg corticotropin-releasing hormone (CRH), 100 μg growth hormone-releasing factor (GRF), and 100 μg luteinizing hormone-releasing hormone (LHRH)
  2. Our patient had low serum levels of insulin-like growth factor 1 (15 ng/mL; reference range, 48–177) and free testosterone (<0.1 pg/mL; reference range, 4.6–16.9)
  3. ACTH arenocorticotropic hormone, GH growth hormone, FSH follicle-stimulating hormone, LH luteinizing hormone